LitCovid-sample-Enju  

PMC:7205724 / 5311-7092 JSONTXT 24 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T873 0-5 CD denotes 3.1.2
T874 7-20 NN denotes Glycosylation
T875 21-34 NN denotes Glycosylation
T876 35-38 CC denotes and
T877 39-42 PRP-DOLLAR- denotes its
T878 43-50 JJ denotes related
T879 51-59 NNS denotes products
T880 59-60 -COMMA- denotes ,
T881 61-65 FW denotes i.e.
T882 65-66 -COMMA- denotes ,
T883 67-74 NNS denotes glycans
T884 74-75 -COMMA- denotes ,
T885 76-85 VBP denotes introduce
T886 86-93 NNS denotes changes
T887 94-96 TO denotes to
T888 97-100 DT denotes the
T889 101-106 JJ denotes viral
T890 107-115 NN denotes envelope
T891 116-120 WDT denotes that
T892 121-125 VBP denotes make
T893 126-129 DT denotes the
T894 130-135 NN denotes virus
T895 136-142 VBN denotes fitted
T896 143-146 IN denotes for
T897 147-158 NN denotes interaction
T898 159-163 IN denotes with
T899 164-167 DT denotes the
T900 168-172 NN denotes host
T901 173-177 NN denotes cell
T902 178-186 NN denotes membrane
T903 187-188 -LRB- denotes [
T904 188-189 CD denotes 5
T905 189-190 -RRB- denotes ]
T906 192-201 RB denotes Generally
T907 201-202 -COMMA- denotes ,
T908 203-210 NNS denotes glycans
T909 211-214 VBP denotes are
T910 215-231 NNS denotes oligosaccharides
T911 232-238 VBN denotes linked
T912 239-241 TO denotes to
T913 242-245 DT denotes the
T914 246-251 JJ denotes dense
T915 252-262 NN denotes decoration
T916 263-265 IN denotes of
T917 266-269 DT denotes the
T918 270-275 NN denotes spike
T919 276-288 NN denotes glycoprotein
T920 290-292 IN denotes In
T921 293-303 JJ denotes particular
T922 303-304 -COMMA- denotes ,
T923 305-310 DT denotes these
T924 311-327 NNS denotes oligosaccharides
T925 328-332 VBP denotes have
T926 333-338 VBN denotes shown
T927 339-341 TO denotes to
T928 342-351 VB denotes influence
T929 352-355 DT denotes the
T930 356-363 NN denotes folding
T931 364-366 IN denotes of
T932 367-370 DT denotes the
T933 371-372 NN denotes S
T934 373-380 NN denotes protein
T935 381-384 CC denotes and
T936 385-396 JJ denotes proteolytic
T937 397-404 NN denotes process
T938 405-407 IN denotes so
T939 408-412 IN denotes that
T940 413-417 PRP denotes they
T941 418-428 VBP denotes facilitate
T942 429-432 DT denotes the
T943 433-438 NN denotes virus
T944 439-443 NN denotes cell
T945 444-449 NN denotes entry
T946 451-459 RB denotes Moreover
T947 459-460 -COMMA- denotes ,
T948 461-462 DT denotes a
T949 463-468 NN denotes virus
T950 469-473 IN denotes with
T951 474-477 DT denotes the
T952 478-490 VBN denotes glycosylated
T953 491-503 NN denotes glycoprotein
T954 504-509 VBZ denotes gains
T955 510-512 DT denotes an
T956 513-518 JJ denotes extra
T957 519-526 NN denotes feature
T958 527-530 IN denotes for
T959 531-533 DT denotes an
T960 534-540 NN denotes escape
T961 541-545 IN denotes from
T962 546-549 DT denotes the
T963 550-556 JJ denotes immune
T964 557-566 NNS denotes responses
T965 568-577 RB denotes Therefore
T966 577-578 -COMMA- denotes ,
T967 579-586 NNS denotes glycans
T968 587-590 VBP denotes are
T969 591-592 DT denotes a
T970 593-597 JJ denotes good
T971 598-604 NN denotes target
T972 605-608 IN denotes for
T973 609-616 NN denotes vaccine
T974 617-623 NN denotes design
T975 625-628 CD denotes Two
T976 629-633 JJ denotes main
T977 634-639 NNS denotes types
T978 640-642 IN denotes of
T979 643-650 NNS denotes glycans
T980 651-654 VBP denotes are
T981 655-663 VBN denotes N-linked
T982 664-667 CC denotes and
T983 668-676 JJ denotes O-linked
T984 677-684 NNS denotes glycans
T985 686-690 DT denotes Both
T986 691-694 VBP denotes are
T987 695-703 VBN denotes released
T988 704-708 IN denotes from
T989 709-722 NNS denotes glycoproteins
T990 724-731 IN denotes Whereas
T991 732-739 NNS denotes enzymes
T992 740-747 VBP denotes fulfill
T993 748-751 DT denotes the
T994 752-764 NN denotes construction
T995 765-767 IN denotes of
T996 768-777 NNS denotes N-glycans
T997 777-778 -COMMA- denotes ,
T998 779-787 JJ denotes chemical
T999 788-795 NNS denotes methods
T1000 796-803 VBP denotes perform
T1001 804-807 DT denotes the
T1002 808-815 NN denotes release
T1003 816-818 IN denotes of
T1004 819-828 NNS denotes O-glycans
T1005 830-839 NNS denotes N-glycans
T1006 840-843 VBP denotes are
T1007 844-850 VBN denotes linked
T1008 851-853 TO denotes to
T1009 854-857 DT denotes the
T1010 858-863 JJ denotes amino
T1011 864-868 NN denotes acid
T1012 869-879 NN denotes asparagine
T1013 880-881 -LRB- denotes (
T1014 881-884 NN denotes Asn
T1015 884-885 -RRB- denotes )
T1016 886-894 NNS denotes residues
T1017 895-896 -LRB- denotes (
T1018 896-903 JJ denotes Asn-any
T1019 904-909 NN denotes amino
T1020 910-915 NNS denotes acids
T1021 916-922 IN denotes except
T1022 923-926 IN denotes for
T1023 927-935 NN denotes proline-
T1024 936-939 NN denotes Ser
T1025 940-942 CC denotes or
T1026 943-946 NN denotes Thr
T1027 946-947 -RRB- denotes )
T1028 948-957 VBG denotes utilizing
T1029 958-960 DT denotes an
T1030 961-973 JJ denotes N-glycosidic
T1031 974-978 NN denotes bond
T1032 978-979 -COMMA- denotes ,
T1033 980-986 RB denotes mostly
T1034 987-1006 NN denotes N-acetylglucosamine
T1035 1008-1017 NNS denotes O-glycans
T1036 1018-1021 VBP denotes are
T1037 1022-1030 VBN denotes attached
T1038 1031-1033 TO denotes to
T1039 1034-1037 DT denotes the
T1040 1038-1043 JJ denotes amino
T1041 1044-1048 NN denotes acid
T1042 1049-1055 NN denotes serine
T1043 1056-1057 -LRB- denotes (
T1044 1057-1060 NN denotes Ser
T1045 1060-1061 -RRB- denotes )
T1046 1062-1065 CC denotes and
T1047 1066-1075 NN denotes threonine
T1048 1076-1077 -LRB- denotes (
T1049 1077-1080 NN denotes Thr
T1050 1080-1081 -RRB- denotes )
T1051 1082-1090 NNS denotes residues
T1052 1091-1093 IN denotes by
T1053 1094-1097 DT denotes the
T1054 1098-1106 NN denotes addition
T1055 1107-1109 IN denotes of
T1056 1110-1112 DT denotes an
T1057 1113-1121 NN denotes N-acetyl
T1058 1122-1135 NN denotes galactosamine
T1059 1136-1137 -LRB- denotes (
T1060 1137-1143 NN denotes GalNAc
T1061 1143-1144 -RRB- denotes )
T1062 1146-1149 IN denotes For
T1063 1150-1157 NN denotes example
T1064 1157-1158 -COMMA- denotes ,
T1065 1159-1168 NNS denotes N-glycans
T1066 1169-1174 VBP denotes exist
T1067 1175-1177 IN denotes in
T1068 1178-1184 NNP denotes Hendra
T1069 1185-1190 NN denotes virus
T1070 1190-1191 -COMMA- denotes ,
T1071 1192-1200 NN denotes SARS-CoV
T1072 1200-1201 -COMMA- denotes ,
T1073 1202-1211 NN denotes influenza
T1074 1212-1217 NN denotes virus
T1075 1217-1218 -COMMA- denotes ,
T1076 1219-1228 NN denotes hepatitis
T1077 1229-1234 NN denotes virus
T1078 1234-1235 -COMMA- denotes ,
T1079 1236-1241 NN denotes HIV-1
T1080 1241-1242 -COMMA- denotes ,
T1081 1243-1246 CC denotes and
T1082 1247-1251 NNP denotes West
T1083 1252-1256 NNP denotes Nile
T1084 1257-1262 NN denotes virus
T1085 1263-1264 -LRB- denotes [
T1086 1264-1265 CD denotes 6
T1087 1265-1266 -RRB- denotes ]
T1088 1266-1267 -COMMA- denotes ,
T1089 1268-1271 CC denotes and
T1090 1272-1281 NNS denotes O-glycans
T1091 1282-1286 VBP denotes have
T1092 1287-1295 VBN denotes occurred
T1093 1296-1298 IN denotes in
T1094 1299-1302 DT denotes the
T1095 1303-1308 NNP denotes Ebola
T1096 1309-1314 NN denotes virus
T1097 1316-1319 DT denotes The
T1098 1320-1329 JJ denotes 2019-nCoV
T1099 1330-1331 NN denotes S
T1100 1332-1339 NN denotes protein
T1101 1340-1348 VBZ denotes includes
T1102 1349-1351 CD denotes 13
T1103 1352-1355 CC denotes and
T1104 1356-1365 JJ denotes 9N-linked
T1105 1366-1379 NN denotes glycosylation
T1106 1380-1387 NNS denotes sequons
T1107 1388-1390 IN denotes in
T1108 1391-1394 DT denotes the
T1109 1395-1397 NN denotes S1
T1110 1398-1401 CC denotes and
T1111 1402-1404 NN denotes S2
T1112 1405-1412 NN denotes subunit
T1113 1412-1413 -COMMA- denotes ,
T1114 1414-1426 RB denotes respectively
T1115 1427-1428 -LRB- denotes [
T1116 1428-1429 CD denotes 3
T1117 1429-1430 -RRB- denotes ]
T1118 1432-1435 DT denotes All
T1119 1436-1438 IN denotes of
T1120 1439-1444 DT denotes these
T1121 1445-1449 VBP denotes have
T1122 1450-1460 RB denotes previously
T1123 1461-1469 VBD denotes occurred
T1124 1470-1472 IN denotes in
T1125 1473-1476 DT denotes the
T1126 1477-1485 JJ denotes SARS-CoV
T1127 1486-1487 NN denotes S
T1128 1488-1500 NN denotes glycoprotein
T1129 1500-1501 -COMMA- denotes ,
T1130 1502-1508 IN denotes except
T1131 1509-1512 IN denotes for
T1132 1513-1524 JJ denotes four-linked
T1133 1525-1538 NN denotes glycosylation
T1134 1539-1546 NNS denotes sequons
T1135 1547-1549 IN denotes in
T1136 1550-1553 DT denotes the
T1137 1554-1556 NN denotes S1
T1138 1558-1562 RB denotes Also
T1139 1562-1563 -COMMA- denotes ,
T1140 1564-1567 JJ denotes due
T1141 1568-1570 TO denotes to
T1142 1571-1574 DT denotes the
T1143 1575-1584 NN denotes existence
T1144 1585-1587 IN denotes of
T1145 1588-1590 DT denotes an
T1146 1591-1596 JJ denotes amino
T1147 1597-1601 NN denotes acid
T1148 1602-1609 NN denotes proline
T1149 1610-1612 IN denotes in
T1150 1613-1616 DT denotes the
T1151 1617-1626 JJ denotes polybasic
T1152 1627-1635 NN denotes cleavage
T1153 1636-1640 NN denotes site
T1154 1640-1641 -COMMA- denotes ,
T1155 1642-1647 WDT denotes which
T1156 1648-1653 VBZ denotes makes
T1157 1654-1657 DT denotes the
T1158 1658-1666 VBN denotes inserted
T1159 1667-1675 NN denotes sequence
T1160 1676-1680 NN denotes PRRA
T1161 1680-1681 -COMMA- denotes ,
T1162 1682-1687 EX denotes there
T1163 1688-1691 VBP denotes are
T1164 1692-1697 CD denotes three
T1165 1698-1706 JJ denotes O-linked
T1166 1707-1714 NNS denotes glycans
T1167 1715-1725 VBN denotes introduced
T1168 1726-1728 TO denotes to
T1169 1729-1732 DT denotes the
T1170 1733-1742 JJ denotes 2019-nCoV
T1171 1743-1746 NN denotes RBD
T1172 1747-1755 NNS denotes residues
T1173 1756-1760 NN denotes S673
T1174 1760-1761 -COMMA- denotes ,
T1175 1762-1766 NN denotes T678
T1176 1766-1767 -COMMA- denotes ,
T1177 1768-1771 CC denotes and
T1178 1772-1776 NN denotes S686
T1179 1777-1778 -LRB- denotes [
T1180 1778-1779 CD denotes 7
T1181 1779-1780 -RRB- denotes ]
R1000 T1007 T1008 arg1Of linked,to
R1001 T1016 T1008 arg2Of residues,to
R1002 T1016 T1009 arg1Of residues,the
R1003 T1016 T1010 arg1Of residues,amino
R1004 T1016 T1011 arg1Of residues,acid
R1005 T1016 T1012 arg1Of residues,asparagine
R1006 T1016 T1013 arg1Of residues,(
R1007 T1014 T1013 arg2Of Asn,(
R1008 T1015 T1013 arg3Of ),(
R1009 T1016 T1017 arg1Of residues,(
R1010 T1020 T1017 arg2Of acids,(
R1011 T1027 T1017 arg3Of ),(
R1012 T1020 T1018 arg1Of acids,Asn-any
R1013 T1020 T1019 arg1Of acids,amino
R1014 T1022 T1021 arg1Of for,except
R1015 T1020 T1022 arg1Of acids,for
R1016 T1025 T1022 arg2Of or,for
R1017 T1025 T1023 arg1Of or,proline-
R1018 T1024 T1025 arg1Of Ser,or
R1019 T1026 T1025 arg2Of Thr,or
R1020 T1016 T1028 arg1Of residues,utilizing
R1021 T1031 T1028 arg2Of bond,utilizing
R1022 T1031 T1029 arg1Of bond,an
R1023 T1031 T1030 arg1Of bond,N-glycosidic
R1024 T1031 T1032 arg1Of bond,","
R1025 T1034 T1032 arg2Of N-acetylglucosamine,","
R1026 T1034 T1033 arg1Of N-acetylglucosamine,mostly
R1027 T1035 T1036 arg1Of O-glycans,are
R1028 T1037 T1036 arg2Of attached,are
R1029 T1035 T1037 arg2Of O-glycans,attached
R1030 T1037 T1038 arg1Of attached,to
R1031 T1051 T1038 arg2Of residues,to
R1032 T1051 T1039 arg1Of residues,the
R1033 T1042 T1040 arg1Of serine,amino
R1034 T1042 T1041 arg1Of serine,acid
R1035 T1051 T1042 arg1Of residues,serine
R1036 T1042 T1043 arg1Of serine,(
R1037 T1044 T1043 arg2Of Ser,(
R1038 T1045 T1043 arg3Of ),(
R1039 T1042 T1046 arg1Of serine,and
R1040 T1047 T1046 arg2Of threonine,and
R1041 T1051 T1047 arg1Of residues,threonine
R1042 T1047 T1048 arg1Of threonine,(
R1043 T1049 T1048 arg2Of Thr,(
R1044 T1050 T1048 arg3Of ),(
R1045 T1037 T1052 arg1Of attached,by
R1046 T1054 T1052 arg2Of addition,by
R1047 T1054 T1053 arg1Of addition,the
R1048 T1054 T1055 arg1Of addition,of
R1049 T1058 T1055 arg2Of galactosamine,of
R1050 T1058 T1056 arg1Of galactosamine,an
R1051 T1058 T1057 arg1Of galactosamine,N-acetyl
R1052 T1058 T1059 arg1Of galactosamine,(
R1053 T1060 T1059 arg2Of GalNAc,(
R1054 T1061 T1059 arg3Of ),(
R1055 T1089 T1062 arg1Of and,For
R1056 T1063 T1062 arg2Of example,For
R1057 T1089 T1064 arg1Of and,","
R1058 T1065 T1066 arg1Of N-glycans,exist
R1059 T1066 T1067 arg1Of exist,in
R1060 T1081 T1067 arg2Of and,in
R1061 T1069 T1068 arg1Of virus,Hendra
R1062 T1069 T1070 arg1Of virus,","
R1063 T1071 T1070 arg2Of SARS-CoV,","
R1064 T1070 T1072 arg1Of ",",","
R1065 T1074 T1072 arg2Of virus,","
R1066 T1074 T1073 arg1Of virus,influenza
R1067 T1072 T1075 arg1Of ",",","
R1068 T1077 T1075 arg2Of virus,","
R1069 T1077 T1076 arg1Of virus,hepatitis
R1070 T1075 T1078 arg1Of ",",","
R1071 T1079 T1078 arg2Of HIV-1,","
R1072 T1081 T1080 arg1Of and,","
R1073 T1078 T1081 arg1Of ",",and
R1074 T1084 T1081 arg2Of virus,and
R1075 T1083 T1082 arg1Of Nile,West
R1076 T1084 T1083 arg1Of virus,Nile
R1077 T1084 T1085 arg1Of virus,[
R1078 T1086 T1085 arg2Of 6,[
R1079 T1087 T1085 arg3Of ],[
R1080 T1089 T1088 arg1Of and,","
R1081 T1066 T1089 arg1Of exist,and
R1082 T1092 T1089 arg2Of occurred,and
R1083 T1090 T1091 arg1Of O-glycans,have
R1084 T1092 T1091 arg2Of occurred,have
R1085 T1090 T1092 arg1Of O-glycans,occurred
R1086 T1092 T1093 arg1Of occurred,in
R1087 T1096 T1093 arg2Of virus,in
R1088 T1096 T1094 arg1Of virus,the
R1089 T1096 T1095 arg1Of virus,Ebola
R1090 T1100 T1097 arg1Of protein,The
R1091 T1100 T1098 arg1Of protein,2019-nCoV
R1092 T1100 T1099 arg1Of protein,S
R1093 T1100 T1101 arg1Of protein,includes
R1094 T1106 T1101 arg2Of sequons,includes
R1095 T1106 T1102 arg1Of sequons,13
R1096 T1106 T1103 arg1Of sequons,and
R1097 T1106 T1104 arg1Of sequons,9N-linked
R1098 T1106 T1105 arg1Of sequons,glycosylation
R1099 T1106 T1107 arg1Of sequons,in
R1100 T1112 T1107 arg2Of subunit,in
R1101 T1112 T1108 arg1Of subunit,the
R1102 T1112 T1109 arg1Of subunit,S1
R1103 T1109 T1110 arg1Of S1,and
R1104 T1111 T1110 arg2Of S2,and
R1105 T1112 T1111 arg1Of subunit,S2
R1106 T1106 T1113 arg1Of sequons,","
R1107 T1106 T1114 arg1Of sequons,respectively
R1108 T1101 T1115 arg1Of includes,[
R1109 T1116 T1115 arg2Of 3,[
R1110 T1117 T1115 arg3Of ],[
R1111 T1118 T1119 arg1Of All,of
R1112 T1120 T1119 arg2Of these,of
R1113 T1118 T1121 arg1Of All,have
R1114 T1123 T1121 arg2Of occurred,have
R1115 T1123 T1122 arg1Of occurred,previously
R1116 T1118 T1123 arg1Of All,occurred
R1117 T1123 T1124 arg1Of occurred,in
R1118 T1128 T1124 arg2Of glycoprotein,in
R1119 T1128 T1125 arg1Of glycoprotein,the
R1120 T1128 T1126 arg1Of glycoprotein,SARS-CoV
R1121 T1128 T1127 arg1Of glycoprotein,S
R1122 T1123 T1129 arg1Of occurred,","
R1123 T1131 T1130 arg1Of for,except
R1124 T1123 T1131 arg1Of occurred,for
R1125 T1134 T1131 arg2Of sequons,for
R1126 T1134 T1132 arg1Of sequons,four-linked
R1127 T1134 T1133 arg1Of sequons,glycosylation
R1128 T1134 T1135 arg1Of sequons,in
R1129 T1137 T1135 arg2Of S1,in
R1130 T1137 T1136 arg1Of S1,the
R1131 T1163 T1138 arg1Of are,Also
R1132 T1163 T1139 arg1Of are,","
R1133 T1141 T1140 arg1Of to,due
R1134 T1163 T1141 arg1Of are,to
R1135 T1143 T1141 arg2Of existence,to
R1136 T1143 T1142 arg1Of existence,the
R1137 T1143 T1144 arg1Of existence,of
R1138 T1148 T1144 arg2Of proline,of
R1139 T1148 T1145 arg1Of proline,an
R1140 T1148 T1146 arg1Of proline,amino
R1141 T1148 T1147 arg1Of proline,acid
R1142 T1148 T1149 arg1Of proline,in
R1143 T1153 T1149 arg2Of site,in
R1144 T1153 T1150 arg1Of site,the
R1145 T1153 T1151 arg1Of site,polybasic
R1146 T1153 T1152 arg1Of site,cleavage
R1147 T1148 T1154 arg1Of proline,","
R1148 T1148 T1155 arg1Of proline,which
R1149 T1148 T1156 arg1Of proline,makes
R1150 T1160 T1156 arg2Of PRRA,makes
R1151 T1160 T1157 arg1Of PRRA,the
R1152 T1160 T1158 arg2Of PRRA,inserted
R1153 T1160 T1159 arg1Of PRRA,sequence
R1154 T1163 T1161 arg1Of are,","
R1155 T1162 T1163 arg1Of there,are
R1156 T1166 T1163 arg2Of glycans,are
R1157 T1166 T1164 arg1Of glycans,three
R1158 T1166 T1165 arg1Of glycans,O-linked
R1159 T1166 T1167 arg2Of glycans,introduced
R1160 T1167 T1168 arg1Of introduced,to
R1161 T1177 T1168 arg2Of and,to
R1162 T1177 T1169 arg1Of and,the
R1163 T1172 T1170 arg1Of residues,2019-nCoV
R1164 T1172 T1171 arg1Of residues,RBD
R1165 T1177 T1172 arg1Of and,residues
R1166 T1173 T1174 arg1Of S673,","
R1167 T1175 T1174 arg2Of T678,","
R1168 T1177 T1176 arg1Of and,","
R1169 T1174 T1177 arg1Of ",",and
R1170 T1178 T1177 arg2Of S686,and
R1171 T1177 T1179 arg1Of and,[
R1172 T1180 T1179 arg2Of 7,[
R1173 T1181 T1179 arg3Of ],[
R871 T874 T873 arg1Of Glycosylation,3.1.2
R872 T875 T876 arg1Of Glycosylation,and
R873 T882 T876 arg2Of ",",and
R874 T882 T877 arg1Of ",",its
R875 T879 T878 arg1Of products,related
R876 T879 T880 arg1Of products,","
R877 T879 T881 arg1Of products,i.e.
R878 T879 T882 arg1Of products,","
R879 T883 T882 arg2Of glycans,","
R880 T885 T884 arg1Of introduce,","
R881 T876 T885 arg1Of and,introduce
R882 T886 T885 arg2Of changes,introduce
R883 T886 T887 arg1Of changes,to
R884 T890 T887 arg2Of envelope,to
R885 T890 T888 arg1Of envelope,the
R886 T890 T889 arg1Of envelope,viral
R887 T886 T891 arg1Of changes,that
R888 T886 T892 arg1Of changes,make
R889 T894 T892 arg2Of virus,make
R890 T894 T893 arg1Of virus,the
R891 T894 T895 arg2Of virus,fitted
R892 T895 T896 arg1Of fitted,for
R893 T897 T896 arg2Of interaction,for
R894 T897 T898 arg1Of interaction,with
R895 T902 T898 arg2Of membrane,with
R896 T902 T899 arg1Of membrane,the
R897 T902 T900 arg1Of membrane,host
R898 T902 T901 arg1Of membrane,cell
R899 T902 T903 arg1Of membrane,[
R900 T904 T903 arg2Of 5,[
R901 T905 T903 arg3Of ],[
R902 T909 T906 arg1Of are,Generally
R903 T909 T907 arg1Of are,","
R904 T908 T909 arg1Of glycans,are
R905 T910 T909 arg2Of oligosaccharides,are
R906 T910 T911 arg2Of oligosaccharides,linked
R907 T911 T912 arg1Of linked,to
R908 T915 T912 arg2Of decoration,to
R909 T915 T913 arg1Of decoration,the
R910 T915 T914 arg1Of decoration,dense
R911 T915 T916 arg1Of decoration,of
R912 T919 T916 arg2Of glycoprotein,of
R913 T919 T917 arg1Of glycoprotein,the
R914 T919 T918 arg1Of glycoprotein,spike
R915 T926 T920 arg1Of shown,In
R916 T921 T920 arg2Of particular,In
R917 T926 T922 arg1Of shown,","
R918 T924 T923 arg1Of oligosaccharides,these
R919 T924 T925 arg1Of oligosaccharides,have
R920 T926 T925 arg2Of shown,have
R921 T924 T926 arg1Of oligosaccharides,shown
R922 T928 T927 arg1Of influence,to
R923 T926 T927 modOf shown,to
R924 T930 T928 arg2Of folding,influence
R925 T930 T929 arg1Of folding,the
R926 T930 T931 arg1Of folding,of
R927 T935 T931 arg2Of and,of
R928 T935 T932 arg1Of and,the
R929 T934 T933 arg1Of protein,S
R930 T934 T935 arg1Of protein,and
R931 T937 T935 arg2Of process,and
R932 T937 T936 arg1Of process,proteolytic
R933 T928 T938 arg1Of influence,so
R934 T941 T938 arg2Of facilitate,so
R935 T938 T939 arg1Of so,that
R936 T940 T941 arg1Of they,facilitate
R937 T945 T941 arg2Of entry,facilitate
R938 T945 T942 arg1Of entry,the
R939 T945 T943 arg1Of entry,virus
R940 T945 T944 arg1Of entry,cell
R941 T954 T946 arg1Of gains,Moreover
R942 T954 T947 arg1Of gains,","
R943 T949 T948 arg1Of virus,a
R944 T949 T950 arg1Of virus,with
R945 T953 T950 arg2Of glycoprotein,with
R946 T953 T951 arg1Of glycoprotein,the
R947 T953 T952 arg2Of glycoprotein,glycosylated
R948 T949 T954 arg1Of virus,gains
R949 T957 T954 arg2Of feature,gains
R950 T957 T955 arg1Of feature,an
R951 T957 T956 arg1Of feature,extra
R952 T957 T958 arg1Of feature,for
R953 T960 T958 arg2Of escape,for
R954 T960 T959 arg1Of escape,an
R955 T960 T961 arg1Of escape,from
R956 T964 T961 arg2Of responses,from
R957 T964 T962 arg1Of responses,the
R958 T964 T963 arg1Of responses,immune
R959 T968 T965 arg1Of are,Therefore
R960 T968 T966 arg1Of are,","
R961 T967 T968 arg1Of glycans,are
R962 T971 T968 arg2Of target,are
R963 T971 T969 arg1Of target,a
R964 T971 T970 arg1Of target,good
R965 T971 T972 arg1Of target,for
R966 T974 T972 arg2Of design,for
R967 T974 T973 arg1Of design,vaccine
R968 T977 T975 arg1Of types,Two
R969 T977 T976 arg1Of types,main
R970 T977 T978 arg1Of types,of
R971 T979 T978 arg2Of glycans,of
R972 T977 T980 arg1Of types,are
R973 T981 T980 arg2Of N-linked,are
R974 T977 T981 arg2Of types,N-linked
R975 T984 T981 arg3Of glycans,N-linked
R976 T984 T982 arg1Of glycans,and
R977 T984 T983 arg1Of glycans,O-linked
R978 T985 T986 arg1Of Both,are
R979 T987 T986 arg2Of released,are
R980 T985 T987 arg2Of Both,released
R981 T987 T988 arg1Of released,from
R982 T989 T988 arg2Of glycoproteins,from
R983 T1000 T990 arg1Of perform,Whereas
R984 T992 T990 arg2Of fulfill,Whereas
R985 T991 T992 arg1Of enzymes,fulfill
R986 T994 T992 arg2Of construction,fulfill
R987 T994 T993 arg1Of construction,the
R988 T994 T995 arg1Of construction,of
R989 T996 T995 arg2Of N-glycans,of
R990 T1000 T997 arg1Of perform,","
R991 T999 T998 arg1Of methods,chemical
R992 T999 T1000 arg1Of methods,perform
R993 T1002 T1000 arg2Of release,perform
R994 T1002 T1001 arg1Of release,the
R995 T1002 T1003 arg1Of release,of
R996 T1004 T1003 arg2Of O-glycans,of
R997 T1005 T1006 arg1Of N-glycans,are
R998 T1007 T1006 arg2Of linked,are
R999 T1005 T1007 arg2Of N-glycans,linked